Scarica l'app Stockscreener
2.125
1.62%
-0.035
Pre-mercato:
2.17
0.045
+2.12%
Precedente Chiudi:
$2.16
Aprire:
$2.21
Volume 24 ore:
13,716
Relative Volume:
0.03
Capitalizzazione di mercato:
$3.72M
Reddito:
-
Utile/perdita netta:
$-15.42M
Rapporto P/E:
-1.1549
EPS:
-1.84
Flusso di cassa netto:
$-13.41M
1 W Prestazione:
-4.71%
1M Prestazione:
-25.18%
6M Prestazione:
+525.46%
1 anno Prestazione:
+118.62%
Intervallo 1D:
$2.12
$2.2233
Intervallo di 1 settimana:
$1.93
$2.44
Portata 52W:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Nome
Indaptus Therapeutics Inc
Settore
Industria
Telefono
(646) 427-2727
Indirizzo
3 COLUMBUS CIRCLE, NEW YORK
Confronta INDP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
2.125 | 3.78M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Indaptus Therapeutics Inc Borsa (INDP) Ultime notizie
How buybacks impact Indaptus Therapeutics Inc. stock valuePortfolio Growth Summary & Real-Time Buy Signal Notifications - BỘ NỘI VỤ
Indaptus Therapeutics (NASDAQ:INDP) Rating Increased to Hold at Wall Street Zen - Defense World
Pullback Watch: How buybacks impact Indaptus Therapeutics Inc. stock valueMarket Weekly Review & Risk Controlled Stock Pick Alerts - moha.gov.vn
Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Nuvalent (NUVL) Receives a New Rating from Truist Financial - The Globe and Mail
Indaptus Therapeutics (INDP) Price Target Decreased by 60.00% to 10.20 - MSN
Volume spikes in Indaptus Therapeutics Inc. stock – what they meanEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Ranking Indaptus Therapeutics Inc. among high performing stocks via toolsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Why Indaptus Therapeutics Inc. stock could see breakout soonPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Will Indaptus Therapeutics Inc. rebound enough to break evenJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com
How high can Indaptus Therapeutics Inc. stock go2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
What momentum indicators show for Indaptus Therapeutics Inc. stockMarket Sentiment Summary & Daily Profit Focused Screening - newser.com
Indaptus Therapeutics 3Q Research and Development Expenses About $1.52M >INDP - 富途牛牛
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - The Manila Times
Why Is Indaptus Therapeutics, Inc. (INDP) Stock Down Today? - Meyka
Indaptus (Nasdaq: INDP) showcases Decoy20 to tackle donor cell variability - Stock Titan
Volatility clustering patterns for Indaptus Therapeutics Inc.Weekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com
Does Indaptus Therapeutics Inc. fit your quant trading modelJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com
Why retail investors pile into Indaptus Therapeutics Inc. stockWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Can Indaptus Therapeutics Inc. stock double in next 5 yearsSwing Trade & Expert Curated Trade Setups - newser.com
Is Indaptus Therapeutics Inc. stock ready for a breakoutWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
Key resistance and support levels for Indaptus Therapeutics Inc.Weekly Profit Summary & Community Verified Watchlist Alerts - newser.com
Exit strategy if you’re trapped in Indaptus Therapeutics Inc.Weekly Volume Report & High Yield Equity Trading Tips - newser.com
Is Indaptus Therapeutics Inc. stock a defensive play in 2025Insider Buying & AI Forecasted Stock Moves - Fundação Cultural do Pará
Visual trend scoring systems applied to Indaptus Therapeutics Inc.July 2025 Summary & Precise Trade Entry Recommendations - newser.com
Indaptus Therapeutics Reports Q3 2025 Financial Results and Corporate Update - Quiver Quantitative
Indaptus Therapeutics Q3 profit beats estimates - MarketScreener
Indaptus Therapeutics Q3 2025 Financial Results and Corporate Update - TradingView
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Indaptus Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Indaptus Therapeutics, Inc. Quarterly Earnings Report | INDP SEC FilingForm 10-Q - Stock Titan
[8-K] Indaptus Therapeutics, Inc. Reports Material Event | INDP SEC FilingForm 8-K - Stock Titan
Indaptus (NASDAQ: INDP) completes Decoy20 safety lead-in; $5.8M cash, runway to Q1 2026 - Stock Titan
Indaptus Therapeutics Inc Azioni (INDP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):